Meton Pharmaceuticals Co., LTD., established in 2015 and basing in Shanghai, China, is dedicated to innovative (first-in-class) drug discovery. Benefiting from the long-time research experience of our scientists in cancer metabolism, Meton’s current R&D strategy is to target tumor-related metabolic enzymes for potential therapeutic solutions. We have built up a comprehensive discovery platform and our team with professional expertise is keeping all projects advancing in fast track. So far, all two projects are on the way from lead optimization to PCC. Innovative, original R&D in compliance with law and regulation are believed to embody our values and fulfill our visions.